- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
NAG-NAG-BMA-MAN-MAN-MAN.2: 16 residues within 4Å:- Chain A: F.5, S.6, P.7, V.202, D.203, D.204, I.233, N.234, Q.243, T.244, K.247, K.731, V.811, E.812, A.813, Q.814
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:D.204, A:K.247
- Water bridges: A:D.203, A:K.247, A:K.247
NAG-NAG-BMA-MAN-MAN-MAN.9: 16 residues within 4Å:- Chain B: F.5, S.6, P.7, V.202, D.203, D.204, I.233, N.234, Q.243, T.244, K.247, K.731, V.811, E.812, A.813, Q.814
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:D.204, B:K.247
- Water bridges: B:K.205, B:K.247, B:K.247
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
NAG-NAG-BMA.3: 13 residues within 4Å:- Chain A: L.291, S.292, F.293, N.297, S.703, S.704, D.705, D.706, P.707
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.4, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.4, NAG.16, EDO.23
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.705
NAG-NAG-BMA.7: 7 residues within 4Å:- Chain A: V.520, S.521, H.522, C.523, N.524, N.544, N.546
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.10: 14 residues within 4Å:- Chain B: I.285, L.291, S.292, F.293, N.297, S.703, S.704, D.705, D.706, P.707
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.11, NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.11, NAG.41, EDO.46
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.705
NAG-NAG-BMA.14: 7 residues within 4Å:- Chain B: V.520, S.521, H.522, C.523, N.524, N.544, N.546
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.4: 33 residues within 4Å:- Chain A: S.6, P.7, P.8, Y.10, E.196, N.235, S.236, Y.237, Q.240, H.267, S.268, G.269, V.270, G.271, F.293, N.297, V.300, S.301, N.304, T.306, S.704, D.706, N.708, Y.709, G.710, W.711, E.715, Y.716, I.717, P.718
- Ligands: NAG-NAG-BMA.3, NAG-NAG-BMA.3, IMD.36
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:N.708, A:P.7, A:N.235, A:G.269, A:V.270, A:D.706, A:G.710, A:W.711
- Water bridges: A:S.268, A:N.708
- Hydrophobic interactions: A:N.297
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.11: 34 residues within 4Å:- Chain B: F.5, S.6, P.7, P.8, Y.10, E.196, N.235, S.236, Y.237, Q.240, H.267, S.268, G.269, V.270, G.271, F.293, N.297, V.300, S.301, N.304, T.306, S.704, D.706, N.708, Y.709, G.710, W.711, E.715, Y.716, I.717, P.718
- Ligands: NAG-NAG-BMA.10, NAG-NAG-BMA.10, EDO.42
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:N.708, B:P.7, B:N.235, B:G.269, B:V.270, B:D.706, B:G.710, B:W.711
- Hydrophobic interactions: B:N.297
- Water bridges: B:N.708
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.6: 16 residues within 4Å:- Chain A: G.466, A.467, S.469, Q.470, D.497, N.499, K.504, N.505, T.507, W.509, K.510, N.511
- Chain B: W.412
- Ligands: NAG-NAG-BMA-MAN.5, NAG-NAG-BMA-MAN.5, NAG-NAG-BMA-MAN-MAN.12
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:D.497
- Hydrogen bonds: A:D.497, A:K.510
- Water bridges: A:D.497, A:N.511, A:N.511
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.13: 15 residues within 4Å:- Chain A: W.412
- Chain B: G.466, A.467, S.469, Q.470, D.497, N.499, K.504, N.505, T.507, W.509, K.510, N.511
- Ligands: NAG-NAG-BMA-MAN-MAN.12, NAG-NAG-BMA-MAN-MAN.12
8 PLIP interactions:8 interactions with chain B- Water bridges: B:N.511, B:N.511, B:G.512, B:E.513
- Hydrophobic interactions: B:D.497, B:W.509
- Hydrogen bonds: B:D.497, B:K.510, B:N.511
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.15: 1 residues within 4Å:- Chain A: N.524
No protein-ligand interaction detected (PLIP)NAG.16: 6 residues within 4Å:- Chain A: R.686, N.696, D.702, S.703, D.705
- Ligands: NAG-NAG-BMA.3
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:D.705
- Hydrogen bonds: A:R.686, A:N.696
NAG.40: 1 residues within 4Å:- Chain B: N.524
No protein-ligand interaction detected (PLIP)NAG.41: 6 residues within 4Å:- Chain B: R.686, N.696, D.702, S.703, D.705
- Ligands: NAG-NAG-BMA.10
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:D.705
- Hydrogen bonds: B:R.686, B:N.696
- 39 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.17: 2 residues within 4Å:- Chain A: Q.477
- Chain B: N.415
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain A: E.451, N.455, Y.569
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain A: Q.446, R.450
- Chain B: Q.446, R.450
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain A: R.375, Y.440, E.559, N.562
- Chain B: I.453
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain A: F.81, S.339, W.340, T.341, R.342, N.437
- Ligands: EDO.26
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain A: S.33, Q.34, M.35, T.36, G.670, E.671
Ligand excluded by PLIPEDO.23: 9 residues within 4Å:- Chain A: G.290, G.295, T.296, Y.680, R.686, F.690, I.691, Y.692
- Ligands: NAG-NAG-BMA.3
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain A: L.64, G.65, I.66, Y.323, Y.324, D.329
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain A: W.49, R.80, S.433, F.493
- Ligands: EDO.34
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain A: E.50, F.81, S.339, W.340
- Ligands: EDO.21
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain A: D.16, K.250, A.251, G.254, T.663
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain A: Y.636, T.637, G.757, N.758, V.759
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain A: R.27, Y.324, G.327, D.329, R.330
Ligand excluded by PLIPEDO.30: 3 residues within 4Å:- Chain A: K.108, D.163
- Ligands: EDO.33
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain A: R.645, Q.647, R.748, V.749, S.750
Ligand excluded by PLIPEDO.32: 6 residues within 4Å:- Chain A: G.395, K.396, E.397, N.455, G.456, G.457
Ligand excluded by PLIPEDO.33: 5 residues within 4Å:- Chain A: Q.162, D.163, V.326, L.331
- Ligands: EDO.30
Ligand excluded by PLIPEDO.34: 8 residues within 4Å:- Chain A: D.74, L.123, K.171, M.227, D.262, W.263, S.433
- Ligands: EDO.25
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain A: Q.183, Y.230, W.263, S.264, F.287
Ligand excluded by PLIPEDO.39: 1 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN.5
Ligand excluded by PLIPEDO.42: 6 residues within 4Å:- Chain B: S.264, H.266, H.267, I.285, F.293
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.11
Ligand excluded by PLIPEDO.43: 2 residues within 4Å:- Chain A: N.415
- Chain B: Q.477
Ligand excluded by PLIPEDO.44: 6 residues within 4Å:- Chain B: I.31, G.65, Y.323, Y.324, D.329
- Ligands: EDO.58
Ligand excluded by PLIPEDO.45: 5 residues within 4Å:- Chain B: K.100, V.152, R.782, K.783, F.784
Ligand excluded by PLIPEDO.46: 8 residues within 4Å:- Chain B: G.290, G.295, T.296, Y.680, F.690, I.691, Y.692
- Ligands: NAG-NAG-BMA.10
Ligand excluded by PLIPEDO.47: 5 residues within 4Å:- Chain A: I.453
- Chain B: R.375, Y.440, E.559, N.562
Ligand excluded by PLIPEDO.48: 5 residues within 4Å:- Chain B: W.49, R.80, S.433, F.493
- Ligands: EDO.49
Ligand excluded by PLIPEDO.49: 8 residues within 4Å:- Chain B: D.74, L.123, K.171, M.227, D.262, W.263, S.433
- Ligands: EDO.48
Ligand excluded by PLIPEDO.50: 4 residues within 4Å:- Chain B: K.250, A.251, G.254, T.663
Ligand excluded by PLIPEDO.51: 3 residues within 4Å:- Chain B: Y.104, K.108, D.163
Ligand excluded by PLIPEDO.52: 6 residues within 4Å:- Chain B: S.33, Q.34, M.35, T.36, G.670, E.671
Ligand excluded by PLIPEDO.53: 3 residues within 4Å:- Chain B: T.819, K.820, Y.821
Ligand excluded by PLIPEDO.54: 4 residues within 4Å:- Chain B: R.645, Q.647, R.748, S.750
Ligand excluded by PLIPEDO.55: 5 residues within 4Å:- Chain B: D.99, T.101, L.102, E.376, R.786
Ligand excluded by PLIPEDO.56: 2 residues within 4Å:- Chain B: Y.762, F.788
Ligand excluded by PLIPEDO.57: 4 residues within 4Å:- Chain B: R.53, P.335, K.359, D.362
Ligand excluded by PLIPEDO.58: 4 residues within 4Å:- Chain B: R.27, E.30, Y.324
- Ligands: EDO.44
Ligand excluded by PLIPEDO.59: 4 residues within 4Å:- Chain B: T.394, E.451, N.455, Y.569
Ligand excluded by PLIPEDO.64: 1 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN-MAN.12
Ligand excluded by PLIP- 7 x IMD: IMIDAZOLE(Non-covalent)
IMD.36: 3 residues within 4Å:- Chain A: W.711, E.715
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.4
1 PLIP interactions:1 interactions with chain A- pi-Stacking: A:W.711
IMD.37: 4 residues within 4Å:- Chain A: N.365, Q.367, R.368
- Chain B: G.456
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.365, A:R.368
IMD.38: 5 residues within 4Å:- Chain A: N.304, G.305, T.306, D.713, R.722
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.304, A:T.306
IMD.60: 5 residues within 4Å:- Chain B: N.201, D.203, D.607, F.608, N.609
3 PLIP interactions:3 interactions with chain B- Water bridges: B:V.202, B:V.202, B:D.203
IMD.61: 4 residues within 4Å:- Chain A: G.456
- Chain B: N.365, Q.367, R.368
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.365, B:R.368
IMD.62: 7 residues within 4Å:- Chain B: G.395, K.396, E.397, V.398, N.455, G.456, G.457
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.455
IMD.63: 3 residues within 4Å:- Chain B: Q.162, D.163, K.325
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.162, B:K.325
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Agirre, J. et al., Three-Dimensional Structures of Two Heavily N-Glycosylated Aspergillus Sp. Family Gh3 Beta-D-Glucosidases. Acta Crystallogr.,Sect.D (2016)
- Release Date
- 2016-02-10
- Peptides
- BETA-GLUCOSIDASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 39 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 7 x IMD: IMIDAZOLE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Agirre, J. et al., Three-Dimensional Structures of Two Heavily N-Glycosylated Aspergillus Sp. Family Gh3 Beta-D-Glucosidases. Acta Crystallogr.,Sect.D (2016)
- Release Date
- 2016-02-10
- Peptides
- BETA-GLUCOSIDASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B